On @Breakingviews: Eli Lilly is close behind Novo Nordisk in releasing a weight loss drug, in a market expected to be worth $50 billion by 2030. But the duoโs success is enticing rivals and smaller players, writes @aimeedonnellan https://t.co/aopwjIiCNG— Reuters (@Reuters) November 28, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


